Hospitalization and Mortality in Patients With Heart Failure Treated With Sacubitril/Valsartan vs. Enalapril: A Real-World, Population-Based Study

MLA

Swathi Pathadka, et al. “Hospitalization and Mortality in Patients With Heart Failure Treated With Sacubitril/Valsartan vs. Enalapril: A Real-World, Population-Based Study.” Frontiers in Cardiovascular Medicine, vol. 7, Jan. 2021. EBSCOhost, https://doi.org/10.3389/fcvm.2020.602363.

APA

Swathi Pathadka, Vincent K. C. Yan, Xue Li, Gary Tse, Eric Y. F. Wan, Hayden Lau, Wallis C. Y. Lau, David C. W. Siu, Esther W. Chan, & Ian C. K. Wong. (2021). Hospitalization and Mortality in Patients With Heart Failure Treated With Sacubitril/Valsartan vs. Enalapril: A Real-World, Population-Based Study. Frontiers in Cardiovascular Medicine, 7. https://doi.org/10.3389/fcvm.2020.602363

Chicago

Swathi Pathadka, Vincent K. C. Yan, Xue Li, Gary Tse, Eric Y. F. Wan, Hayden Lau, Wallis C. Y. Lau, David C. W. Siu, Esther W. Chan, and Ian C. K. Wong. 2021. “Hospitalization and Mortality in Patients With Heart Failure Treated With Sacubitril/Valsartan vs. Enalapril: A Real-World, Population-Based Study.” Frontiers in Cardiovascular Medicine 7 (January). doi:10.3389/fcvm.2020.602363.